Press Release2025 Call for Code Engages Developers to Build AI Solutions that Address Social and Humanitarian Issues In its eighth year, Call for Code presents a series of SDG-focused… CISION PRNewswireMarch 5, 2025
Press ReleaseNewly-formed Archerfish Precision Diagnostics Pte Ltd: Ushers a New Era in Advanced Diagnostics SINGAPORE, March 5, 2025 /PRNewswire/ — In a significant development for the… CISION PRNewswireMarch 5, 2025
Press ReleaseKOCCA Brings the Future of Entertainment to SXSW 2025 – AI, XR, and K-Content Innovation Take Center Stage AUSTIN, Texas, March 5, 2025 /PRNewswire/ — At SXSW 2025, the Korea… CISION PRNewswireMarch 5, 2025
Press ReleaseHOT GIRL WALK IN STYLE: HALARA BRINGS "MADE FOR WHAT MOVES YOU" TO LIFE IN AUSTIN AUSTIN, Texas, March 5, 2025 /PRNewswire/ — Halara, a viral athleisure brand,… CISION PRNewswireMarch 5, 2025
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE FOR MARCH 5TH NEW YORK, March 5, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireMarch 5, 2025
Press ReleaseNORTIV 8 Unveils GeoPilot Tactical Boot Collection Unmatched and Versatile Men’s Tactical Footwear Built for Work, Adventure, and Everyday… CISION PRNewswireMarch 5, 2025
Press ReleaseGlobal Industry Partners Jointly Release Net5.5G Best Practices & Deployment Guide Whitepaper BARCELONA, Spain, March 5, 2025 /PRNewswire/ — At MWC Barcelona 2025, the… CISION PRNewswireMarch 5, 2025
SECuRE trial update: 92% of pre-chemo participants experience greater than 35% drop in PSA levels across all cohorts. Cohort Expansion Phase commences. HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation… CISION PRNewswireMarch 5, 2025
